Fresh analysis reveals that individuals who discontinue popular weight-loss injections like semaglutide or tirzepatide can put back on shed pounds far faster than those who end conventional diet and exercise plans.
Findings released in a leading health publication points out that while overweight people often shed substantial amounts of their total mass while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals using such treatments need to be aware of the danger of quick rebound weight gain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to original mass within about one and a half years.
Weighing Therapies
The analysis, which looked at 37 of trials involving over 9,000 of patients, compared the results of the injectable medications with other pills.
Scientists emphasize that people who shed pounds through lifestyle changes alone generally have a more gradual weight regain—around 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Experts propose the mechanism of the drugs explains the amplified rebound.
The injections copy a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 levels several times higher than the body's typical production might result in the system to produce less of its endogenous hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement results in appetite is uncontrolled, making binge eating much more probable."
A Chronic Condition?
The NHS recommend the jabs for individuals with weight-linked health risks, alongside recommended lifestyle changes.
Many experts contend that, considering the likelihood of relapse, the treatment might need to be ongoing.
This opinion is echoed by pharmaceutical companies, who state that the results "emphasize the chronic nature of excess weight," akin to managing conditions like hypertension.
User Experiences
Users who have discontinued the medication describe a sudden return of cravings.
"I experienced a trigger activating and you become extremely hungry," recalled one woman.
This challenge is exacerbated if users have not established lasting lifestyle or habit changes during therapy.
Growing Interest
Survey data suggest that millions of people in the UK have tried these injections in the last 12 months, with desire remaining high.
- Adoption is greater among females than males.
- The middle-aged demographic shows the highest level of interest.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Ultimately, researchers stress that while these medications are powerful tools for weight loss, they are not a permanent cure and lasting health benefits hinges on ongoing behavioural management.